Last $4.88 USD
Change Today +0.19 / 4.05%
Volume 4.4M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stanley C. Erck

Chief Executive Officer, President, Director and Member of Finance Committee, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 4 different industries.

See Board Relationships
66$1,595,314
As of Fiscal Year 2013

Background*

Mr. Stanley C. Erck, also known as Stan, has been the Chief Executive Officer and President of Novavax, Inc. since April 2011. Mr. Erck served as the Chief Executive Officer and President of Intercell USA Inc. from May 2000 to 2008 and served as its Treasurer since May 2000. He has over 25 years of management experience in the healthcare and biotechnology industry to shepherd the development and commercialization of Iomai technology. Mr. Erck managed the process of developing ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

2000-2008
Former Chief Executive Officer, President, Treasurer and Director
2005-Present
Director
2008-Present
Director and Chairman of Compensation Committee
2009-Present
Chief Executive Officer, President, Director and Member of Finance Committee

Education*

MBA
The University of Chicago
BS
University of Illinois-Urbana-Champaign

Other Affiliations*

Annual Compensation*

Salary$448,250
Total Annual Compensation$448,250

Stock Options*

All Other Compensation$7,967
Exercisable Options820,000
Exercisable Options Value$2,655,850
Unexercisable Options2,000,000
Unexercisable Options Value$6,883,250
Total Value of Options$9,539,100
Total Number of Options2,820,000

Total Compensation*

Total Annual Cash Compensation$695,314
Total Short Term Compensation$448,250
Other Long Term Compensation$7,967
Total Calculated Compensation$1,595,314
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $4.88 USD +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Philippe Archinard Ph.D.Chairman and Chief Executive Officer
Transgene SA
€72.2K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.